Sarkar S, Porel P, Kosey S, Aran K
Inflammopharmacology. 2025; .
PMID: 40057929
DOI: 10.1007/s10787-025-01697-y.
Chang Z, Wang Z, Luo L, Xie Z, Yue C, Bian X
Front Neurosci. 2024; 18:1423892.
PMID: 39539495
PMC: 11557526.
DOI: 10.3389/fnins.2024.1423892.
Soria-Tobar L, Roman-Valero L, Sebastian-Serrano A, Aivar P, Alvarez-Castelao B, Diaz-Hernandez M
Alzheimers Res Ther. 2024; 16(1):233.
PMID: 39438925
PMC: 11494749.
DOI: 10.1186/s13195-024-01600-x.
Flieger J, Forma A, Flieger W, Flieger M, Gawlik P, Dzierzynski E
Int J Mol Sci. 2024; 25(16).
PMID: 39201668
PMC: 11354426.
DOI: 10.3390/ijms25168982.
Alhawarri M, Al-Thiabat M, Dubey A, Tufail A, Fouad D, Alrimawi B
RSC Adv. 2024; 14(14):9878-9891.
PMID: 38528929
PMC: 10961956.
DOI: 10.1039/d4ra01070a.
A Review on the Use of Modern Computational Methods in Alzheimer's Disease-Detection and Prediction.
De A, Mishra T, Saraf S, Tripathy B, Reddy S
Curr Alzheimer Res. 2024; 20(12):845-861.
PMID: 38468529
DOI: 10.2174/0115672050301514240307071217.
Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives.
Bhole R, Chikhale R, Rathi K
IBRO Neurosci Rep. 2024; 16:8-42.
PMID: 38169888
PMC: 10758887.
DOI: 10.1016/j.ibneur.2023.11.003.
Unveiling the Effects of Copper Ions in the Aggregation of Amyloidogenic Proteins.
Oliveri V
Molecules. 2023; 28(18).
PMID: 37764220
PMC: 10537474.
DOI: 10.3390/molecules28186446.
The Strategies of Development of New Non-Toxic Inhibitors of Amyloid Formation.
Galzitskaya O, Grishin S, Glyakina A, Dovidchenko N, Konstantinova A, Kravchenko S
Int J Mol Sci. 2023; 24(4).
PMID: 36835194
PMC: 9964835.
DOI: 10.3390/ijms24043781.
Exploring the Involvement of the Amyloid Precursor Protein A673T Mutation against Amyloid Pathology and Alzheimer's Disease in Relation to Therapeutic Editing Tools.
Stanciu G, Ababei D, Rusu R, Bild V, Tamba B
Pharmaceutics. 2022; 14(6).
PMID: 35745842
PMC: 9228826.
DOI: 10.3390/pharmaceutics14061270.
Therapeutic Efficacies of Berberine against Neurological Disorders: An Update of Pharmacological Effects and Mechanisms.
Shou J, Shaw P
Cells. 2022; 11(5).
PMID: 35269418
PMC: 8909195.
DOI: 10.3390/cells11050796.
Putting Humpty Dumpty Back Together Again: What Does Protein Quantification Mean in Bottom-Up Proteomics?.
Plubell D, Kall L, Webb-Robertson B, Bramer L, Ives A, Kelleher N
J Proteome Res. 2022; 21(4):891-898.
PMID: 35220718
PMC: 8976764.
DOI: 10.1021/acs.jproteome.1c00894.
Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.
Kaur D, Behl T, Sehgal A, Singh S, Sharma N, Bungau S
Neurochem Res. 2021; 46(11):2832-2851.
PMID: 34357520
DOI: 10.1007/s11064-021-03415-w.
The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer's Disease.
Xia Q, Yang X, Shi J, Liu Z, Peng Y, Wang W
Mol Neurobiol. 2021; 58(8):4038-4050.
PMID: 33914267
DOI: 10.1007/s12035-021-02385-y.
The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer's Disease Pathogenesis.
Jasiecki J, Targonska M, Wasag B
Int J Mol Sci. 2021; 22(4).
PMID: 33670778
PMC: 7922581.
DOI: 10.3390/ijms22042033.
Alzheimer's Disease and Protein Kinases.
Engin A, Engin A
Adv Exp Med Biol. 2021; 1275:285-321.
PMID: 33539020
DOI: 10.1007/978-3-030-49844-3_11.
The Role of P2X7 Receptor in Alzheimer's Disease.
Francistiova L, Bianchi C, Di Lauro C, Sebastian-Serrano A, de Diego-Garcia L, Kobolak J
Front Mol Neurosci. 2020; 13:94.
PMID: 32581707
PMC: 7283947.
DOI: 10.3389/fnmol.2020.00094.
S100 Proteins in Alzheimer's Disease.
Cristovao J, Gomes C
Front Neurosci. 2019; 13:463.
PMID: 31156365
PMC: 6532343.
DOI: 10.3389/fnins.2019.00463.
Amyloid Peptide Induced Neuroinflammation Increases the P2X7 Receptor Expression in Microglial Cells, Impacting on Its Functionality.
Martinez-Frailes C, Di Lauro C, Bianchi C, de Diego-Garcia L, Sebastian-Serrano A, Bosca L
Front Cell Neurosci. 2019; 13:143.
PMID: 31031598
PMC: 6474397.
DOI: 10.3389/fncel.2019.00143.
[Osthole suppresses amyloid precursor protein expression by up-regulating miRNA-101a-3p in Alzheimer's disease cell model].
Lin Y, Yao Y, Liang X, Shi Y, Kong L, Xiao H
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019; 47(5):473-479.
PMID: 30693688
PMC: 10393713.
DOI: 10.3785/j.issn.1008-9292.2018.10.05.